SEC Form 4 · accession 0001140361-15-004417
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William R Ringo
Director
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 8:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 3, 2015 | M | 2,200 | $6.41 | A | 3,000 | D | |
| Common Stock | Feb 3, 2015 | S | 2,200 | $12.70 | D | 800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $6.41 | Feb 3, 2015 | M | 2,200 | D | — | May 31, 2021 | Common Stock | 2,200 | 5,600 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2014, as amended.
- F2All shares underlying this option are vested and immediately exercisable.